FDA — authorised 6 August 1971
- Application: NDA016942
- Marketing authorisation holder: WESTWOOD SQUIBB
- Local brand name: HALOTEX
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 HALOPROGIN in United States
FDA authorised HALOPROGIN on 6 August 1971
Marketing authorisations
FDA — authorised 6 August 1971
- Application: NDA016943
- Marketing authorisation holder: WESTWOOD SQUIBB
- Local brand name: HALOTEX
- Indication: SOLUTION — TOPICAL
- Status: approved
FDA
- Marketing authorisation holder: WESTWOOD SQUIBB
- Status: approved
HALOPROGIN in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in United States
Frequently asked questions
Is HALOPROGIN approved in United States?
Yes. FDA authorised it on 6 August 1971; FDA authorised it on 6 August 1971; FDA has authorised it.
Who is the marketing authorisation holder for HALOPROGIN in United States?
WESTWOOD SQUIBB holds the US marketing authorisation.